Literature DB >> 33481820

Improvement of image quality and assessment of respiratory motion for hepatocellular carcinoma with portal vein tumor thrombosis using contrast-enhanced four-dimensional dual-energy computed tomography.

Shingo Ohira1,2, Naoyuki Kanayama1, Kentaro Wada1, Toshiki Ikawa1, Takero Hirata1, Noriko Kishi1,3, Tsukasa Karino1, Hayate Washio1, Yoshihiro Ueda1, Masayoshi Miyazaki1, Masahiko Koizumi2, Teruki Teshima1.   

Abstract

To assess the objective and subjective image quality, and respiratory motion of hepatocellular carcinoma with portal vein tumor thrombosis (PVTT) using the contrast-enhanced four-dimensional dual-energy computed tomography (CE-4D-DECT). For twelve patients, the virtual monochromatic image (VMI) derived from the CE-4D-DECT with the highest contrast to noise ratio (CNR) was determined as the optimal VMI (O-VMI). To assess the objective and subjective image quality, the CNR and five-point score of the O-VMI were compared to those of the standard VMI at 77 keV (S-VMI). The respiratory motion of the PVTT and diaphragm was measured based on the exhale and inhale phase images. The VMI at 60 keV yielded the highest CNR (4.8 ± 1.4) which was significantly higher (p = 0.02) than that in the S-VMI (3.8 ± 1.2). The overall image quality (4.0 ± 0.6 vs 3.1 ± 0.5) and tumor conspicuity (3.8 ± 0.8 vs 2.8 ± 0.6) of the O-VMI determined by three radiation oncologists was significantly higher (p < 0.01) than that of the S-VMI. The diaphragm motion in the L-R (3.3 ± 2.5 vs 1.2 ± 1.1 mm), A-P (6.7 ± 4.0 vs 1.6 ± 1.3mm) and 3D (8.8 ± 3.5 vs 13.1 ± 4.9 mm) directions were significantly larger (p < 0.05) compared to the tumor motion. The improvement of objective and subjective image quality was achieved in the O-VMI. Because the respiratory motion of the diaphragm was larger than that of the PVTT, we need to be pay attention for localizing target in radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33481820      PMCID: PMC7822294          DOI: 10.1371/journal.pone.0244079

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  24 in total

1.  Virtual Monochromatic Images from Dual-Energy Multidetector CT: Variance in CT Numbers from the Same Lesion between Single-Source Projection-based and Dual-Source Image-based Implementations.

Authors:  Achille Mileto; Andrew Barina; Daniele Marin; Sandra S Stinnett; Kingshuk Roy Choudhury; Joshua M Wilson; Rendon C Nelson
Journal:  Radiology       Date:  2015-11-04       Impact factor: 11.105

2.  Clinical implementation of contrast-enhanced four-dimensional dual-energy computed tomography for target delineation of pancreatic cancer.

Authors:  Shingo Ohira; Kentaro Wada; Takero Hirata; Naoyuki Kanayama; Toshiki Ikawa; Tsukasa Karino; Yuya Nitta; Masaru Isono; Yoshihiro Ueda; Masayoshi Miyazaki; Masahiko Koizumi; Teruki Teshima
Journal:  Radiother Oncol       Date:  2018-02-06       Impact factor: 6.280

3.  Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.

Authors:  Tae Hyun Kim; Dae Yong Kim; Joong-Won Park; Seong Hoon Kim; Joon-Il Choi; Hyun Beom Kim; Woo Jin Lee; Sang Jae Park; Eun Kyung Hong; Chang-Min Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-10-23       Impact factor: 7.038

4.  Hepatocellular carcinoma in Central Europe: prognostic features and survival.

Authors:  M Schöniger-Hekele; C Müller; M Kutilek; C Oesterreicher; P Ferenci; A Gangl
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

5.  Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma.

Authors:  Sandro Rossi; Giorgia Ghittoni; Valentina Ravetta; Francesca Torello Viera; Laura Rosa; Martina Serassi; Mara Scabini; Alessandro Vercelli; Carmine Tinelli; Barbara Dal Bello; Peter N Burns; Fabrizio Calliada
Journal:  Eur Radiol       Date:  2008-03-28       Impact factor: 5.315

6.  Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma.

Authors:  Gregory C Connolly; Rui Chen; Ollivier Hyrien; Parvez Mantry; Adel Bozorgzadeh; Peter Abt; Alok A Khorana
Journal:  Thromb Res       Date:  2007-11-28       Impact factor: 3.944

7.  Is diaphragm motion a good surrogate for liver tumor motion?

Authors:  Juan Yang; Jing Cai; Hongjun Wang; Zheng Chang; Brian G Czito; Mustafa R Bashir; Manisha Palta; Fang-Fang Yin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-12       Impact factor: 7.038

Review 8.  The general rules for the clinical and pathological study of primary liver cancer. Liver Cancer Study Group of Japan.

Authors: 
Journal:  Jpn J Surg       Date:  1989-01

9.  Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.

Authors:  Onofrio A Catalano; Garry Choy; Andrew Zhu; Peter F Hahn; Dushyant V Sahani
Journal:  Radiology       Date:  2010-01       Impact factor: 11.105

10.  How to Best Detect Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Meeting the Milan Criteria: Gadoxetic Acid-Enhanced MRI versus Contrast-Enhanced CT.

Authors:  Jae Seok Bae; Jeong Min Lee; Jeong Hee Yoon; Siwon Jang; Jin Wook Chung; Kyung Bun Lee; Nam-Joon Yi; Jeong-Hoon Lee
Journal:  Liver Cancer       Date:  2020-01-28       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.